Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
Unbroken sun on Tuesday with good sunny spells for the next few days. Breakdown at weekend
The NCA have thanked spanish police for capturing one of their most wanted criminals. Paul Monk is wanted over the murder of Liverpool man.
Nearly half a million people registered to vote in the 24 hours before yesterday's midnight deadline, the Electoral Commission has said